[Clinical application and significance of drug delivery systems in cancer chemotherapy].
Tsukagoshi
S
S
D000818:Animals; D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001682:Biological Availability; D004337:Drug Carriers; D006801:Humans; D007136:Immunoglobulins; D046911:Macromolecular Substances; D008299:Maleic Anhydrides; D009369:Neoplasms / Q000188:drug therapy*; D011137:Polystyrenes; D009353:Zinostatin / Q000031:analogs & derivatives
D000970:Antineoplastic Agents; D004337:Drug Carriers; D007136:Immunoglobulins; D046911:Macromolecular Substances; D008299:Maleic Anhydrides; D011137:Polystyrenes; C035755:poly(maleic acid-styrene)neocarzinostatin; D009353:Zinostatin